FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility
Summary
The acquisition aligns with FairJourney’s ongoing strategic growth plan, and will significantly bolster the Company’s antibody discovery and engineering capabilities, strengthening its technology portfolio and expanding its global presence with a key biotechnology hub in the US. The acquisition of the South San Francisco site, formerly Distributed Bio, will transfer ownership of all facilities, staff and assets to FairJourney Biologics, including proprietary technologies such as the SuperHuman™, Cosmic™ and Tungsten™ libraries. Establishing facilities in this region forms a core part of the Company’s ongoing development strategy, strengthening its reach and physical presence in a major global market. The acquisition will provide customers in this region with a localized source of expertise and technical support, helping them to accelerate their antibody discovery and engineering pipelines. The deal will also enable FairJourney to leverage the industry-leading scientific expertise of the South San Francisco team, promoting new opportunities for collaborative projects, both internally and with leading global biotech and pharmaceutical companies.